Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis

被引:16
|
作者
Provenzano, Carlo [1 ]
Marino, Mariapaola [1 ]
Scuderi, Flavia [1 ]
Evoli, Amelia [2 ]
Bartoccioni, Emanuela [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Gen Pathol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Neurosci, I-00168 Rome, Italy
关键词
Autoantibodies; Acetylcholinesterase; Neuromuscular junction; Sympathetic system; Myasthenia gravis; ACETYLCHOLINESTERASE ANTIBODIES; NEUROMUSCULAR-TRANSMISSION; AUTOIMMUNE; THYROGLOBULIN; EXPRESSION; GENE; CHOLINESTERASES; OPHTHALMOPATHY; DISORDERS; JUNCTION;
D O I
10.1016/j.jneuroim.2009.11.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In MG, anti-AChR or anti-MuSK abs impair neuromuscular transmission. Partial inhibition of ACH can ameliorate symptoms, while a complete block causes a cholinergic blockade. We found anti-AChE abs in 115/240 MG patients, with no correlation with sex, age at onset, thymus pathology, presence of anti-AM or anti-MuSK antibodies. We found a correlation with the ocular form of the disease, and with milder forms of MG not requiring immunosuppressants; moreover, when we considered only those patients who were off AChEI therapy, we found that ocular patients were positive for anti-AChE abs, while generalized patients were negative. According to an experimental model, we hypothesize that anti-AChE abs could contribute to ptosis through an inhibition of the sympathetic innervation of the tarsal muscle. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 50 条
  • [21] CHARACTERIZATION OF ANTIBODIES TO ACETYLCHOLINESTERASE IN SERUM FROM PATIENTS WITH MYASTHENIA-GRAVIS
    KEESEY, J
    CHAO, LP
    HERRMANN, C
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 767 - 768
  • [22] Myasthenia Gravis Patients with Anti-MuSK Antibodies
    Zagar, Marija
    Vranjes, Davorka
    Sostarko, Marija
    Vogrinc, Zeljka
    Bilic, Ervina
    Cepe, Milica Trbojevic
    COLLEGIUM ANTROPOLOGICUM, 2009, 33 (04) : 1151 - 1154
  • [23] The features of myasthenia gravis with anti-MuSK antibodies
    Lavrnic, D
    De Baets, M
    Vujic, A
    Hajdukovic, L
    Stojanovic, V
    Trikic, R
    Djukic, P
    Apostolski, S
    JOURNAL OF NEUROLOGY, 2004, 251 : 182 - 183
  • [24] Development of generalized myasthenia gravis in patients with ocular myasthenia gravis
    Papapetropoulos, TH
    Ellul, J
    Tsibri, E
    ARCHIVES OF NEUROLOGY, 2003, 60 (10) : 1491 - 1492
  • [25] Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies
    Johnson, Glynis
    Moore, Samuel W.
    JOURNAL OF MOLECULAR RECOGNITION, 2009, 22 (03) : 188 - 196
  • [26] Antibodies in myasthenia gravis
    Eymard, B.
    REVUE NEUROLOGIQUE, 2009, 165 (02) : 137 - 143
  • [27] Acetylcholinesterase inhibitor treatment for myasthenia gravis
    Mehndiratta, Man Mohan
    Pandey, Sanjay
    Kuntzer, Thierry
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (02):
  • [28] THERAPY FOR OCULAR MYASTHENIA GRAVIS
    SMITH, JL
    TRANSACTIONS AMERICAN ACADEMY OF OPHTHALMOLOGY AND OTOLARYNGOLOGY, 1974, 78 (05): : O795 - O798
  • [29] Ocular Neuromyotonia and Myasthenia Gravis
    Jang, JunWon
    Chang, Moohwan
    Kyung, Sungeun
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2015, 52 (03) : 190 - U126
  • [30] Atypical ocular myasthenia gravis
    Milea, D
    Laforet, P
    Eymard, B
    REVUE NEUROLOGIQUE, 2005, 161 (05) : 543 - 548